The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

28 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
14
Mitophagy in Neurodegenerative Diseases: Mechanisms of Action and the Advances of Drug Discovery.EBI
Sichuan Universit
50
Novel highly selective inhibitors of ubiquitin specific protease 30 (USP30) accelerate mitophagy.EBI
Mitobridge, Inc. (An Astellas)
36
Discovery of Potent, Selective, and Orally Bioavailable Inhibitors of USP7 with In Vivo Antitumor Activity.EBI
Rapt Therapeutics
2
The medicinal chemistry of mitochondrial dysfunction: a critical overview of efforts to modulate mitochondrial health.EBI
Msd The Francis Crick Institute
219
COMPOUND AS FAK INHIBITOR AND USE THEREOFBDB
Wigen Biomedicine Technology (Shanghai)
478
N-(5-SUBSTITUTED-[(1,3,4-THIADIAZOLYL) OR (THIAZOLYL)])(SUBSTITUTED)CARBOXAMIDE COMPOUNDS AND USE THEREOF FOR INHIBITING HUMAN POLYMERASE THETABDB
Repare Therapeutics
65
MALT1 MODULATORS AND USES THEREOFBDB
Rheos Medicines
46
2-AMINOPYRIMIDINE COMPOUND AND PHARMACEUTICAL COMPOSITION THEREOF AND APPLICATION THEREOFBDB
Guangzhou Salustier Biosciences
1
CRYSTALLINE FORM OF TLR8 AGONISTBDB
Chia Tai Tianqing Pharmaceutical Group
170
COMPOUND USEFUL AS CDK7 KINASE INHIBITOR AND USE THEREOFBDB
Tyk Medicines
13
Treatment of upper aerodigestive tract disorders and coughBDB
Individual
177
Serine/threonine kinase inhibitorsBDB
Genentech
229
CompoundsBDB
Tmem16A
42
Benzamide compoundsBDB
Recurium Ip Holding
17
Ghrelin O-acyltransferase inhibitorsBDB
Glaxosmithkline Intellectual Property Development
7
Pyrazolo-heteroaryl derivative, preparation method and medical use thereofBDB
Jiangsu Hengrui Medicine
224
Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitorsBDB
Mirati Therapeutics
107
Oxopicolinamide derivative, preparation method therefor and pharmaceutical use thereofBDB
Jiangsu Hengrui Medicine
21
Quinolinone lysyl oxidase-like 2 inhibitors and uses thereofBDB
Pharmakea
69
Aromatic acetylene or aromatic ethylene compound, intermediate, preparation method, pharmaceutical composition and use thereofBDB
Guangzhou Maxinovel Pharmaceuticals Co.
17
Ethynyl derivativesBDB
Hoffmann-La Roche
88
Alkyl pyrrolopyrimidine analogs and methods of making and using sameBDB
University of North Carolina at Chapel Hill
512
Small molecule inhibitors of lactate dehydrogenase and methods of use thereofBDB
Department Of Health And Human Services
6
Fused imidazoles as mIDH1 inhibitorsBDB
Bayer
42
Xanthine derivatives, their use as a medicament, and pharmaceutical preparations comprising the sameBDB
Max Delbruck Center
31
Tricyclic rho kinase inhibitorsBDB
Bristol Myers Squibb
19
C5-C6-oxacyclic fused iminothiadiazine dioxide compounds bearing an ether linker as BACE inhibitors, compositions, and their useBDB
Merck Sharp & Dohme
29
InhibitorsBDB
Probiodrug